Company intelligence / Profile preview
Center for Genetic Engineering and Biotechnology
Havana, Cubaicgeb.org ↗
- Ownership
- Private
- Employees
- ~1600
- Development stage
- Commercial
01
Overview
CIGB has developed several commercialized products including the recombinant epidermal growth factor-based therapy Heberprot-P for diabetic foot ulcers, which significantly reduces amputation rates. The center also developed the Abdala COVID‑19 vaccine, authorized for emergency use in Cuba and other countries, as well as Mambisa, a nasal COVID‑19 vaccine candidate that reached late-stage clinical trials. Its pipeline includes biopharmaceuticals and agricultural biotech products.
- Therapeutic areas
- EndocrinologyInfectious Diseases
- Modalities
- VaccineRecombinant proteinMonoclonal antibodyPolyclonal antibodyEnzyme replacement therapy (enzymes)Diagnostic test (device/diagnostic)
- Industry
- Biotech
02
Drug pipeline
34 assets33 more assets in the full pipeline.
Request access →03
Partnerships
CIGB has joint ventures with Chinese partners as of at least 2020; it collaborates internationally on research and commercialization. Specific partner names are not listed.
Beyond the preview
Go deeper on Center for Genetic Engineering and Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Center for Genetic Engineering and Biotechnology.